106 related articles for article (PubMed ID: 15701343)
1. [CA125 cytosolic levels in lung adenocarcinomas. New biological aspects].
Ruibal A; Nuñez Cambre I; Sánchez Salmón A; Nuñez MI; Rodríguez J
Rev Esp Med Nucl; 2005; 24(1):27-31. PubMed ID: 15701343
[TBL] [Abstract][Full Text] [Related]
2. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
[TBL] [Abstract][Full Text] [Related]
3. [CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters].
Ruibal A; Núñez MI; Del Río MC; Lapeña G; Rodríguez J
Rev Esp Med Nucl; 2002; 21(5):333-7. PubMed ID: 12236907
[TBL] [Abstract][Full Text] [Related]
4. [CD44s Cell surface expression in 55 lung adenocarcinomas. Negative correlation with tumor size and CA125 cytosolic levels].
Ruibal A; Núñez MI; del Río MC; Pardo C; Rodríguez J
Rev Esp Med Nucl; 2003; 22(2):82-6. PubMed ID: 12646096
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of cytosolic tissue-type plasminogen activator levels in lung adenocarcinomas].
Ruibal A; Núñez MI; Del Río MC; Rodríguez J; Alvarez De Linera JF
Med Clin (Barc); 2002 Jun; 119(1):1-3. PubMed ID: 12061997
[TBL] [Abstract][Full Text] [Related]
6. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
[TBL] [Abstract][Full Text] [Related]
7. [Cytosolic cathepsin D levels in squamous carcinomas of the lung].
Ruibal A; Núñez MI; Río Mdel C; García Díez S; Rodríguez J; Alvarez de Linera JF
Med Clin (Barc); 2003 Feb; 120(3):81-4. PubMed ID: 12605727
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung.
Ruibal A; Nuñez MI; Rodríguez J; Jiménez L; del Rio MC; Zapatero J
Int J Biol Markers; 2003; 18(3):188-94. PubMed ID: 14535589
[TBL] [Abstract][Full Text] [Related]
9. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.
Afify AM; Tate S; Durbin-Johnson B; Rocke DM; Konia T
Int J Biol Markers; 2011; 26(1):50-7. PubMed ID: 21279958
[TBL] [Abstract][Full Text] [Related]
11. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
[TBL] [Abstract][Full Text] [Related]
12. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast].
Ruibal A; Arias J; del Río MC; San Román JM; Lapeña G; Pardo C; Tejerina A
Rev Esp Med Nucl; 2000 Oct; 19(6):428-33. PubMed ID: 11060273
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas.
Hong RL; Lee WJ; Shun CT; Chu JS; Chen YC
Oncology; 1995; 52(4):334-9. PubMed ID: 7539903
[TBL] [Abstract][Full Text] [Related]
16. Concordance between serum and cytosolic levels of CEA, CA125 and SCC antigens in patients with non-small cell lung cancer.
Diez M; Pollan M; Maestro ML; Ortega MD; Gomez A; Sanchez-Pernaute A; Torres A; Granell J; Balibrea JL
Anticancer Res; 1995; 15(6B):2811-7. PubMed ID: 8669870
[TBL] [Abstract][Full Text] [Related]
17. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
[TBL] [Abstract][Full Text] [Related]
18. Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: association with high cellular proliferation and high concentrations of EGFR and CD44v5.
Ruibal Á; Aguiar P; Del Río MC; Nuñez MI; Pubul V; Herranz M
Int J Mol Sci; 2015 Feb; 16(3):4372-8. PubMed ID: 25809603
[TBL] [Abstract][Full Text] [Related]
19. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
[TBL] [Abstract][Full Text] [Related]
20. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]